Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920474 · ClinicalTrials.gov registry record
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
A clinical trial of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.
- Recruiting
- Registry status
- 1
- Study location
NCT04920474: Recruiting study of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.
NCT04920474 is a study of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation that is actively recruiting participants, run by Center for International Blood and Marrow Transplant Research. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04920474, a study of Allogeneic Stem Cell Transplantation and Autologous Stem Cell Transplantation, is actively recruiting participants, sponsored by Center for International Blood and Marrow Transplant Research.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may request access to research samples contained in the Research Sample Repository for the purpose of conducting research including: * investigating molecular explanations for histocompatibility or clinical outcomes through analysis of genomic, epigenetic, or other biomolecular data * evaluating the factors that affect transplant or cellular therapy outcome * studying the distribution of HLA tissue types in different populations * studying the success of transplantation, cellular therapies or supportive care in the management of marrow toxic injuries * performing de-linked (anonymous) research
Conditions Studied
Study Locations (1)
Minnesota
- NMDP Biorepository - New Brighton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 1991-07 |
| Est. Completion | 2030-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920474
The ClinicalTrials.gov registry entry for NCT04920474 describes a study currently listed as recruiting, categorized as an unspecified phase. The registry lists this as an open-ended (no fixed target) study, common for long-running registries and repositories that collect data indefinitely rather than recruiting toward a fixed participant count. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Allogeneic Stem Cell Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT04920474 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04920474 about?
NCT04920474 is a clinical study titled "Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries". The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may reque...
What is the current status of trial NCT04920474?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 1991-07. Estimated completion is 2030-07.
What conditions does trial NCT04920474 study?
This clinical trial studies the following conditions: Allogeneic Stem Cell Transplantation, Autologous Stem Cell Transplantation, Cellular Therapy, Marrow Toxic Injury.
Who is sponsoring clinical trial NCT04920474?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04920474 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allogeneic Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT
RECRUITING · Phase 2
-
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
RECRUITING · Phase 2
-
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
RECRUITING · Phase 2
-
CIBMTR Research Database
RECRUITING
-
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Allogeneic Stem Cell Transplantation
All registered trials for this condition
Autologous Stem Cell Transplantation
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.